Redefining typhoid diagnosis: what would an improved test need to look like?

Richard G Mather, Heidi Hopkins, Christopher M Parry, Sabine Dittrich, Richard G Mather, Heidi Hopkins, Christopher M Parry, Sabine Dittrich

Abstract

Introduction: Typhoid fever is one of the most common bacterial causes of acute febrile illness in the developing world, with an estimated 10.9 million new cases and 116.8 thousand deaths in 2017. Typhoid point-of-care (POC) diagnostic tests are widely used but have poor sensitivity and specificity, resulting in antibiotic overuse that has led to the emergence and spread of multidrug-resistant strains. With recent advances in typhoid surveillance and detection, this is the ideal time to produce a target product profile (TPP) that guides product development and ensure that a next-generation test meets the needs of users in the resource-limited settings where typhoid is endemic.

Methods: A structured literature review was conducted to develop a draft TPP for a next-generation typhoid diagnostic test with minimal and optimal desired characteristics for 36 test parameters. The TPP was refined using feedback collected from a Delphi survey of key stakeholders in clinical medicine, microbiology, diagnostics and public and global health.

Results: A next-generation typhoid diagnostic test should improve patient management through the diagnosis and treatment of infection with acute Salmonella enterica serovars Typhi or Paratyphi with a sensitivity ≥90% and specificity ≥95%. The test would ideally be used at the lowest level of the healthcare system in settings without a reliable power or water supply and provide results in <15 min at a cost of <US$1.00.

Conclusion: This report outlines the first comprehensive TPP for typhoid fever and is intended to guide the development of a next-generation typhoid diagnostic test. An accurate POC test will reduce the morbidity and mortality of typhoid fever through rapid diagnosis and treatment and will have the greatest impact in reducing antimicrobial resistance if it is combined with diagnostics for other causes of acute febrile illness in a treatment algorithm.

Keywords: Other diagnostic or tool; Public Health; diagnostics and tools; typhoid and paratyphoid fevers.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. MacFadden DR, Bogoch II, Andrews JR. Advances in diagnosis, treatment, and prevention of invasive Salmonella infections. Curr Opin Infect Dis 2016;29:453–8. 10.1097/QCO.0000000000000302
    1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1789–858. 10.1016/S0140-6736(18)32279-7
    1. Dicker D, Nguyen G, Abate D, et al. . Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1684–735. 10.1016/S0140-6736(18)31891-9
    1. Maskey AP, Day JN, Phung QT, et al. . Salmonella enterica serovar paratyphi A and S. enterica serovar typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006;42:1247–53. 10.1086/503033
    1. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006;333:78–82. 10.1136/bmj.333.7558.78
    1. Parry CM, Wijedoru L, Arjyal A, et al. . The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev Anti Infect Ther 2011;9:711–25. 10.1586/eri.11.47
    1. Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: current challenges and future directions. Vaccine 2015;33:C8–15. 10.1016/j.vaccine.2015.02.030
    1. Klemm EJ, Shakoor S, Page AJ, et al. . Emergence of an extensively drug-resistant Salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio 2018;9:e00105–18. 10.1128/mBio.00105-18
    1. Basnyat B. Typhoid versus typhus fever in post-earthquake Nepal. Lancet Glob Health 2016;4:e516–7. 10.1016/S2214-109X(16)30094-8
    1. Schroeder LF, Elbireer A, Jackson JB, et al. . Laboratory Diagnostics Market in East Africa : A Survey of Test Types, Test Availability, and Test Prices in Kampala, Uganda. PLoS Negl Trop Dis 2015;10:e0134578.
    1. Raffatellu M, Wilson RP, Winter SE, et al. . Clinical pathogenesis of typhoid fever. J Infect Dev Ctries 2008;2:260–6.
    1. Baker S, Favorov M, Dougan G. Searching for the elusive typhoid diagnostic. BMC Infect Dis 2010;10:45 10.1186/1471-2334-10-45
    1. Wain J, Diep TS, Ho VA, et al. . Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998;36:1683–7.
    1. Khanam F, Sheikh A, Sayeed MA, et al. . Evaluation of a Typhoid/Paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh. PLoS Negl Trop Dis 2013;7:e2316 10.1371/journal.pntd.0002316
    1. World Health Organization Typhoid vaccines: WHO position paper - March 2018. Geneva, 2018. Available:
    1. von Kalckreuth V, Konings F, Aaby P, et al. . The typhoid fever surveillance in Africa program (TSAP): clinical, diagnostic, and epidemiological methodologies. Clin Infect Dis 2016;62:S9–16. 10.1093/cid/civ693
    1. Tulip Diagnostics Tydal widal antigen set. Available: [Accessed 20 Aug 2018].
    1. IDL Biotech AB TUBEX TF rapid typhoid detection. Available: [Accessed 16 Aug 2018].
    1. Reszon Diagnostics Typhidot rapid IgG/IgM (Combo) version 2, 2014. Available: [Accessed 16 Aug 2018].
    1. LifeAssay Diagnostics Test-itTM typhoid IgM lateral flow assay, 2016. Available: [Accessed 16 Aug 2018].
    1. Das S, Rajendran K, Dutta P, et al. . Validation of a new serology-based dipstick test for rapid diagnosis of typhoid fever. Diagn Microbiol Infect Dis 2013;76:5–9. 10.1016/j.diagmicrobio.2013.01.012
    1. World Health Organization Communicable Disease Surveillance and Response Vaccines and Biologicals Background document: the diagnosis, treatment and prevention of typhoid fever. Geneva, 2003. Available:
    1. Wijedoru L, Mallett S, Parry CM. Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever. Cochrane Database Syst Rev 2017;5 10.1002/14651858.CD008892.pub2
    1. Islam K, Sayeed MA, Hossen E, et al. . Comparison of the performance of the TPTest, Tubex, Typhidot and widal immunodiagnostic assays and blood cultures in detecting patients with typhoid fever in Bangladesh, including using a Bayesian latent class modeling approach. PLoS Negl Trop Dis 2016;10:e0004558 10.1371/journal.pntd.0004558
    1. Felgner J, Jain A, Nakajima R, et al. . Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children. PLoS Negl Trop Dis 2017;11:e0005679 10.1371/journal.pntd.0005679
    1. Bruxvoort KJ, Leurent B, Chandler CIR, et al. . The impact of introducing malaria rapid diagnostic tests on fever case management: a synthesis of ten studies from the act Consortium. Am J Trop Med Hyg 2017;97:1170–9. 10.4269/ajtmh.16-0955
    1. Marks F, von Kalckreuth V, Aaby P, et al. . Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. The Lancet Global Health 2017;5:e310–23. 10.1016/S2214-109X(17)30022-0
    1. Dittrich S, Tadesse BT, Moussy F, et al. . Target product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: an expert consensus. PLoS One 2016;11:e0161721–12. 10.1371/journal.pone.0161721
    1. Denkinger CM, Dolinger D, Schito M, et al. . Target product profile of a molecular drug-susceptibility test for use in microscopy centers. J Infect Dis 2015;211:S39–49. 10.1093/infdis/jiu682
    1. Das JK, Hasan R, Zafar A, et al. . Trends, associations, and antimicrobial resistance of Salmonella typhi and paratyphi in Pakistan. Am J Trop Med Hyg 2018;99:48–54. 10.4269/ajtmh.18-0145
    1. Ghani AC, Burgess DH, Reynolds A, et al. . Expanding the role of diagnostic and prognostic tools for infectious diseases in resource-poor settings. Nature 2015;528:S50–2. 10.1038/nature16038
    1. Mogasale V, Ramani E, Mogasale VV, et al. . What proportion of Salmonella typhi cases are detected by blood culture? A systematic literature review. Ann Clin Microbiol Antimicrob 2016;15:32 10.1186/s12941-016-0147-z
    1. Storey HL, Huang Y, Crudder C, et al. . A meta-analysis of typhoid diagnostic accuracy studies: a recommendation to adopt a standardized composite reference. PLoS One 2015;10:e0142364 10.1371/journal.pone.0142364
    1. Obaro SK, Iroh Tam P-Y, Mintz ED, et al. . The unrecognized burden of typhoid fever. Expert Rev Vaccines 2017;16:249–60. 10.1080/14760584.2017.1255553
    1. Thriemer K, Ley B, Menten J, et al. . A systematic review and meta-analysis of the performance of two point of care typhoid fever tests, Tubex TF and Typhidot, in endemic countries. PLoS One 2013;8:e81263 10.1371/journal.pone.0081263
    1. Maude RR, de Jong HK, Wijedoru L, et al. . The diagnostic accuracy of three rapid diagnostic tests for typhoid fever at Chittagong medical college Hospital, Chittagong, Bangladesh. Trop Med Int Health 2015;20:1376–84. 10.1111/tmi.12559
    1. Andrews JR, Arora P, Bogoch II, et al. . Understanding the potential value of new diagnostics for enteric fever : insights from decision analytic modeling. Am J Trop Med Hyg 2017;97.
    1. Ding XC, Ade MP, Baird JK, et al. . Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: target product profiles. PLoS Negl Trop Dis 2017;11:e0005516–15. 10.1371/journal.pntd.0005516
    1. Chua AC, Cunningham J, Moussy F, et al. . The case for improved diagnostic tools to control Ebola virus disease in West Africa and how to get there. PLoS Negl Trop Dis 2015;9:e0003734 10.1371/journal.pntd.0003734
    1. Urdea M, Penny LA, Olmsted SS, et al. . Requirements for high impact diagnostics in the developing world. Nature 2006;444:73–9. 10.1038/nature05448
    1. Radhakrishnan A, Als D, Mintz ED, et al. . Introductory article on global burden and epidemiology of typhoid fever. Am J Trop Med Hyg 2018;99:4–9. 10.4269/ajtmh.18-0032
    1. Darton TC, Blohmke CJ, Pollard AJ. Typhoid epidemiology, diagnostics and the human challenge model. Curr Opin Gastroenterol 2014;30:7–17. 10.1097/MOG.0000000000000021
    1. McKinnon LR, Karim QA. Host-Pathogen interactions: honing in on enteric fever. Elife 2014;3:e03545.
    1. Neuzil KM, Pollard AJ, Marfin AA. Introduction of typhoid conjugate vaccines in Africa and Asia. Clin Infect Dis 2019;68:S27–30. 10.1093/cid/ciy878
    1. Hopkins H, Bruxvoort KJ, Cairns ME, et al. . Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ 2017;356 10.1136/bmj.j1054
    1. Parry CM, Ribeiro I, Walia K, et al. . Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities. BMJ 2019;37 10.1136/bmj.k5322
    1. Steele AD, Hay Burgess DC, Diaz Z, et al. . Challenges and opportunities for typhoid fever control: a call for coordinated action. Clin Infect Dis 2016;62:S4–8. 10.1093/cid/civ976
    1. Shao AF, Rambaud-Althaus C, Samaka J, et al. . New algorithm for managing childhood illness using mobile technology (ALMANACH): a controlled non-inferiority study on clinical outcome and antibiotic use in Tanzania. PLoS One 2015;10:e0132316 10.1371/journal.pone.0132316
    1. Kim J-Y, Ji S-Y, Goo Y-K, et al. . Comparison of rapid diagnostic tests for the detection of Plasmodium vivax malaria in South Korea. PLoS One 2013;8:64353 10.1371/journal.pone.0064353
    1. World Health Organization Laboratory biosafety manual - Third edition. Geneva, 2004. Available:
    1. World Health Organization Risk based classification of diagnostics for who prequalification, 2014. Available: [Accessed 1 Aug 2018].

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren